Systematic review of hematopoietic stem cell gene therapy approach in thalassemia: Comparative analysis in animal models

Hematopoietic stem cell (HSC) gene therapy has shown potential as a therapeutic approach for thalassemia in recent years. However, a comparison of the varying gene therapy methods of HSC gene therapy in thalassemia has never been reviewed. This study aims to evaluate the utilization of HSC gene ther...

Full description

Saved in:
Bibliographic Details
Published in:European journal of haematology 2024-06, Vol.112 (6), p.848-859
Main Authors: Maharani, Indira Laksmi, Zauhari, Muhammad Hafizh, Kiansantang, Rakean Ahmad, Wibowo, Razzan Satria, Humaira, Rizqi Najla, Dwijayanti, Adisti, Sianipar, Imelda Rosalyn
Format: Article
Language:English
Subjects:
animal model
Animal models
Animals
beta-Globins - genetics
Blood diseases
Cell culture
Comparative analysis
Disease Models, Animal
Erythrocytes
Gene therapy
Genetic Therapy - methods
hematopoietic stem cell
Hematopoietic Stem Cell Transplantation - methods
Hematopoietic stem cells
Hematopoietic Stem Cells - metabolism
Humans
in vivo
Mice
Phenotypes
Reviews
Stem cells
Systematic review
Thalassemia
Thalassemia - genetics
Thalassemia - therapy
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hematopoietic stem cell (HSC) gene therapy has shown potential as a therapeutic approach for thalassemia in recent years. However, a comparison of the varying gene therapy methods of HSC gene therapy in thalassemia has never been reviewed. This study aims to evaluate the utilization of HSC gene therapy approaches in animal models of thalassemia. A systematic review was conducted in five databases: PubMed, EBSCOHost, Science Direct, SCOPUS, and Proquest using a combination of the terms hematopoietic stem cell or hematopoietic stem cell or HSC, thalassemia, genetic therapy or gene therapy and animal model. Only journals published in English between 2008 and 2023 were included. This literature included six studies analyzing the use of HSC gene therapy in thalassemic mice models. The three outcomes being assessed in this review were globin levels, hematological parameters, and red blood cell (RBC) phenotypes. Gene therapy approaches for thalassemia using HSC showed significant improvement in β‐globin levels and RBC phenotypes. Phenotypic improvements were also observed. These outcomes indicate good efficacy in gene therapy for thalassemia in mice models. Furthermore, more studies assessing the efficacy of HSC gene therapy in the human model should be done in future studies.
ISSN:0902-4441
1600-0609
DOI:10.1111/ejh.14179